Novel Marine-Derived Anti-Cancer Agents
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3417-3426
Author(s):
Thomas E. Adrian
Connecting A Tumor to the Environment
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3440-3444
Author(s):
Frank Entschladen, Daniel Palm, Theodore L. Drell IV,, Kerstin Lang and Kurt S. Zaenker
Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
633-642
Author(s):
Theresa L. Whiteside
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
650-665
Author(s):
Igor Astsaturov, Roger B. Cohen and Paul Harari
Targeting MDM2 and MDMX in Retinoblastoma
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
689-695
Author(s):
Nikia A. Laurie, Chie Schin-Shih and Michael A. Dyer
Intracellular Delivery of Nanocarriers for Cancer Therapy
Journal:
Current Nanoscience
Volume:
3
Page:
329-338
Author(s):
Yah-el Har-el and Yoshinori Kato
Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
236-241
Author(s):
Teresa Troiani, Tina Cascone, John Heymach and Fortunato Ciardiello
γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies
Journal:
Current Molecular Medicine
Volume:
7
Page:
658-673
Author(s):
Angelo Martino and Fabrizio Poccia
Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
6
Page:
315-331
Author(s):
Jin-Zhang Zeng and Xiao-kun Zhang
Molecular Targets of FoxP3+ Regulatory T Cells
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
1136-1143
Author(s):
Chang H. Kim